MMP9 and experimental autoimmune encephalomyelitis: CD147 is an upstream mediator of MMP-9 activity and has been linked to an increased inflammatory response and enhanced leukocyte recruitment in models of experimental autoimmune encephalomyelitis, where inhibition of CD147 blocks leukocyte entry and reduces disease severity [15].